that is associated with this bacterial infection. Clostridioides difficile (previously known as Clostridium difficile) is a highly contagious organism that primarily impacts people over age 65 ...

and it also may inhibit neighboring bacteria, which would give C. diff a further competitive advantage within the gut ...

diff infection and point to novel therapeutic strategies ... and in a novel MiniBioreactor model that contains a community of bacteria isolated from human feces with added 4-thiouracil.

Pfizer's vaccine for Clostridium difficile (C. US biotech Vedanta Biosciences has been awarded up to $76.9 million to develop VE303 for high-risk Clostridioides difficile (C. diff.) infection by ...

A group of gut bacteria successfully hindered recurrent Clostridium difficile infection in mice, offering alternative therapeutic strategies to antibiotics and fecal transplant. To investigate whether ...

Mild Clostridium difficile infection (CDI; stool frequency <four-times daily; no signs of severe colitis), clearly induced by the use of antibiotics, may be treated by stopping the inducing ...

difficile, a notoriously difficult-to-treat bacterial infection, according to a team of researchers. The targeted treatment was as effective as human fecal transplants in mice against C.

Patients suffering from a recurrent infection with the C difficile bacteria have benefited from a microbiome treatment from Rebiotix. The results from the open label phase 2 trial confirm that ...

New insights into a "friendly virus" that could pave the way for cutting-edge treatments for the potentially fatal superbug C ...

difficile infections as an alternative to antibiotics and conventional fecal microbiota transplants. While it draws on the idea of human fecal transplants, a medical procedure where bacteria from ...